PMID- 11064440
OWN - NLM
STAT- MEDLINE
DCOM- 20010104
LR  - 20170214
IS  - 1352-4585 (Print)
IS  - 1352-4585 (Linking)
VI  - 6
IP  - 5
DP  - 2000 Oct
TI  - Histocompatibility antigen (HLA) associations with multiple sclerosis in Iran.
PG  - 317-9
AB  - Human leukocyte antigen (HLA) types were obtained from 79 Iranian patients with 
      multiple sclerosis and compared with 100 controls. The prevalence of HLA-A24 
      (30.3% versus 18.0%), HLA-DR2 (43.0% versus 28. 0%) and HLA-DR15 (36.7% versus 
      23.0%) were significantly increased in multiple sclerosis patients compared with 
      controls. However age at onset, and disease status (relapsing - remitting or 
      primary progressive) did not show an association with any particular HLA type. 
      Multiple Sclerosis (2000) 6 317 - 319
FAU - Kalanie, H
AU  - Kalanie H
AD  - Department of Neurology, Shohada Hospital, Tajrish, Tehran, Iran.
FAU - Kamgooyan, M
AU  - Kamgooyan M
FAU - Sadeghian, H
AU  - Sadeghian H
FAU - Kalanie, A R
AU  - Kalanie AR
LA  - eng
PT  - Journal Article
PL  - England
TA  - Mult Scler
JT  - Multiple sclerosis (Houndmills, Basingstoke, England)
JID - 9509185
RN  - 0 (HLA-A Antigens)
RN  - 0 (HLA-A24 Antigen)
RN  - 0 (HLA-DR Antigens)
RN  - 0 (HLA-DR Serological Subtypes)
RN  - 0 (HLA-DR15 antigen)
RN  - 0 (HLA-DR2 Antigen)
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Age of Onset
MH  - B-Lymphocytes/immunology
MH  - Female
MH  - Genetic Predisposition to Disease
MH  - HLA-A Antigens/*analysis/*immunology
MH  - HLA-A24 Antigen
MH  - HLA-DR Antigens/*analysis/*immunology
MH  - HLA-DR Serological Subtypes
MH  - HLA-DR2 Antigen/analysis/immunology
MH  - Humans
MH  - Iran/epidemiology
MH  - Male
MH  - Middle Aged
MH  - Multiple Sclerosis, Relapsing-Remitting/epidemiology/genetics/*immunology
EDAT- 2000/11/07 11:00
MHDA- 2001/02/28 10:01
CRDT- 2000/11/07 11:00
PHST- 2000/11/07 11:00 [pubmed]
PHST- 2001/02/28 10:01 [medline]
PHST- 2000/11/07 11:00 [entrez]
AID - 10.1177/135245850000600504 [doi]
PST - ppublish
SO  - Mult Scler. 2000 Oct;6(5):317-9. doi: 10.1177/135245850000600504.